Table 3.
Demographic characteristics, biochemical parameters, and medications of patients.
| Exitus (n: 31) | Alive (n: 138) | p value | |
|---|---|---|---|
| Age (years) | 60.6 ± 20.0 | 53.4 ± 13.4 | 0.027 |
| Gender (male) | 27 (15.9%) | 96 (56.8%) | 0.248 |
| Duration of hemodialysis (years) | 7.6 ± 5.4 | 9.5 ± 5.7 | 0.121 |
| Hemoglobin (g/dl) | 10.6 ± 1.03 | 10.8 ± 1.2 | 0.530 |
| Hb-var (g/dl)∗ | 0.94 (0.25) | 0.89 (0.26) | 0.578 |
| Maximum Hb-var (g/dl)∗ | 3.2 (1.7) | 3.3 (1.7) | 0.565 |
| Coefficient of Hb-var∗ | 8.8 (3.1) | 8.4 (3.0) | 0.429 |
| RDW (%)∗ | 16.2 (1.6) | 16.3 (2) | 0.733 |
| Leukocyte (×103/µl) | 7.0 ± 1.7 | 6.6 ± 1.7 | 0.354 |
| MCV (fl) | 89.7 ± 4.9 | 90.1 ± 5.5 | 0.788 |
| Serum Iron (mg/dl)∗ | 53.5 (16.3) | 58.2 (23.2) | 0.206 |
| Transferrin saturation (%)∗ | 29.7 (11.7) | 29.7 (18.3) | 0.301 |
| Ferritin (µg/l)∗ | 344.2 (297.7) | 305.3 (317.1) | 0.478 |
| PTH (pg/ml)∗ | 252.1 (419) | 415 (699) | 0.092 |
| Calcium (mg/dl) | 9.1 ± 0.6 | 9.1 ± 0.7 | 0.988 |
| Phosphate (mg/dl) | 5.1 ± 1.2 | 5.2 ± 1.3 | 0.615 |
| Albumin (g/dl) | 4.0 ± 0.3 | 4.2 ± 0.4 | 0.150 |
| CRP (mg/l)∗ | 16.7 (21.0) | 8.2 (11.4) | 0.008 |
| URR (%) | 66.5 ± 5.5 | 66.0 ± 6.6 | 0.693 |
| MİS∗ | 8 (3) | 6 (3) | 0.002 |
| ESA total dose per body weight (U/kg) ∗ | 4.1 (2.3) | 3.1 (3.8) | 0.066 |
| İron per body weight (mg/kg) ∗ | 13.2 (23.1) | 15.7 (21.5) | 0.542 |
| Months of hb < 11 g/dl | 6.9 ± 3.1 | 6.2 ± 3.8 | 0.379 |
| BMI (kg/m2) | 21.0 ± 3.8 | 23.0 ± 4.5 | 0.046 |
| 10 year survival∗ | 2 (37) | 21 (75) | 0.011 |
HA: high-amplitude fluctuation; LAH: low-amplitude fluctuation with high hemoglobin; LAL: low-amplitude fluctuation with low hemoglobin; Hb-var (hemoglobin variability); MCV: mean corpuscular volume; RDW: red blood cell distribution width; CRP: C-reactive protein; PTH: parathyroid hormone; URR: urea reduction ratio; MIS: malnutrition-inflammation score; ESA: erythropoiesis-stimulating agents; BMI: body mass index, ∗Median (interquartile range) other results are given as mean ± standard deviation.